30-Day Morbidity and Mortality of Bariatric Surgery During the COVID-19 Pandemic: a Multinational Cohort Study of 7704 Patients from 42 Countries.
Bariatric surgery
COVID-19
Obesity surgery
Pandemic
Revisional surgery
SARS-CoV-2
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
15
03
2021
accepted:
20
05
2021
revised:
14
05
2021
pubmed:
31
7
2021
medline:
28
9
2021
entrez:
30
7
2021
Statut:
ppublish
Résumé
There are data on the safety of cancer surgery and the efficacy of preventive strategies on the prevention of postoperative symptomatic COVID-19 in these patients. But there is little such data for any elective surgery. The main objectives of this study were to examine the safety of bariatric surgery (BS) during the coronavirus disease 2019 (COVID-19) pandemic and to determine the efficacy of perioperative COVID-19 protective strategies on postoperative symptomatic COVID-19 rates. We conducted an international cohort study to determine all-cause and COVID-19-specific 30-day morbidity and mortality of BS performed between 01/05/2020 and 31/10/2020. Four hundred ninety-nine surgeons from 185 centres in 42 countries provided data on 7704 patients. Elective primary BS (n = 7084) was associated with a 30-day morbidity of 6.76% (n = 479) and a 30-day mortality of 0.14% (n = 10). Emergency BS, revisional BS, insulin-treated type 2 diabetes, and untreated obstructive sleep apnoea were associated with increased complications on multivariable analysis. Forty-three patients developed symptomatic COVID-19 postoperatively, with a higher risk in non-whites. Preoperative self-isolation, preoperative testing for SARS-CoV-2, and surgery in institutions not concurrently treating COVID-19 patients did not reduce the incidence of postoperative COVID-19. Postoperative symptomatic COVID-19 was more likely if the surgery was performed during a COVID-19 peak in that country. BS can be performed safely during the COVID-19 pandemic with appropriate perioperative protocols. There was no relationship between preoperative testing for COVID-19 and self-isolation with symptomatic postoperative COVID-19. The risk of postoperative COVID-19 risk was greater in non-whites or if BS was performed during a local peak.
Sections du résumé
BACKGROUND
There are data on the safety of cancer surgery and the efficacy of preventive strategies on the prevention of postoperative symptomatic COVID-19 in these patients. But there is little such data for any elective surgery. The main objectives of this study were to examine the safety of bariatric surgery (BS) during the coronavirus disease 2019 (COVID-19) pandemic and to determine the efficacy of perioperative COVID-19 protective strategies on postoperative symptomatic COVID-19 rates.
METHODS
We conducted an international cohort study to determine all-cause and COVID-19-specific 30-day morbidity and mortality of BS performed between 01/05/2020 and 31/10/2020.
RESULTS
Four hundred ninety-nine surgeons from 185 centres in 42 countries provided data on 7704 patients. Elective primary BS (n = 7084) was associated with a 30-day morbidity of 6.76% (n = 479) and a 30-day mortality of 0.14% (n = 10). Emergency BS, revisional BS, insulin-treated type 2 diabetes, and untreated obstructive sleep apnoea were associated with increased complications on multivariable analysis. Forty-three patients developed symptomatic COVID-19 postoperatively, with a higher risk in non-whites. Preoperative self-isolation, preoperative testing for SARS-CoV-2, and surgery in institutions not concurrently treating COVID-19 patients did not reduce the incidence of postoperative COVID-19. Postoperative symptomatic COVID-19 was more likely if the surgery was performed during a COVID-19 peak in that country.
CONCLUSIONS
BS can be performed safely during the COVID-19 pandemic with appropriate perioperative protocols. There was no relationship between preoperative testing for COVID-19 and self-isolation with symptomatic postoperative COVID-19. The risk of postoperative COVID-19 risk was greater in non-whites or if BS was performed during a local peak.
Identifiants
pubmed: 34328624
doi: 10.1007/s11695-021-05493-9
pii: 10.1007/s11695-021-05493-9
pmc: PMC8323543
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4272-4288Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Lancet Diabetes Endocrinol. 2021 Jan;9(1):7-9
pubmed: 33253631
Lancet Diabetes Endocrinol. 2020 Jul;8(7):640-648
pubmed: 32386567
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Obes Rev. 2020 Nov;21(11):e13128
pubmed: 32845580
Obes Surg. 2020 Sep;30(9):3624-3627
pubmed: 32314249
Ann Surg. 2011 Oct;254(4):633-40
pubmed: 21897200
Lancet. 2016 Apr 2;387(10026):1397-1404
pubmed: 26895675
Lancet Diabetes Endocrinol. 2020 Jun;8(6):474-475
pubmed: 32359411
Obes Surg. 2020 Oct;30(10):4159-4164
pubmed: 32458364
Ann Surg. 2014 Jan;259(1):123-30
pubmed: 23470583
Lancet Diabetes Endocrinol. 2020 Aug;8(8):652-654
pubmed: 32653052
JAMA. 2010 Jul 28;304(4):435-42
pubmed: 20664044
Am Surg. 2019 Oct 1;85(10):1108-1112
pubmed: 31657304
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
BMJ Open. 2017 Oct 12;7(10):e015453
pubmed: 29025827
Colorectal Dis. 2020 Jun;22(6):625-634
pubmed: 32233064
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Bone Jt Open. 2020 Sep 14;1(9):562-567
pubmed: 33215155
Br J Surg. 2021 Jan 27;108(1):88-96
pubmed: 33640908
BMJ Open. 2020 Dec 29;10(12):e045309
pubmed: 33376185
J Clin Oncol. 2021 Jan 1;39(1):66-78
pubmed: 33021869
J Neuroimaging. 2020 Sep;30(5):555-561
pubmed: 32776617
Obes Surg. 2021 Jan;31(1):451-456
pubmed: 32740826
Eur Heart J. 2014 Sep 14;35(35):2383-431
pubmed: 25086026
J Racial Ethn Health Disparities. 2021 Oct;8(5):1161-1167
pubmed: 32946070
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
Br J Surg. 2020 Sep;107(10):e418
pubmed: 32735700
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
Bone Jt Open. 2020 Nov 02;1(7):392-397
pubmed: 33215129
Am J Case Rep. 2020 Jul 29;21:e925753
pubmed: 32724028
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Bone Jt Open. 2020 Aug 1;1(8):450-456
pubmed: 33215138
ANZ J Surg. 2020 Oct;90(10):1845-1856
pubmed: 32770653
Obes Surg. 2020 Dec;30(12):5101-5107
pubmed: 32829450
Cureus. 2020 Nov 24;12(11):e11682
pubmed: 33391918